A structural aspect of human fibrinogen suggested by its plasmin degradation.

Suppr

超能文献

作者信息

Gaffney P J., Dobos P

机构信息

National Institute for Medical Research, Mill Hill, NW7 1AA, London, England

出版信息

FEBS Lett. 1971 Jun 2;15(1):13-16. doi: 10.1016/0014-5793(71)80067-4.

DOI:10.1016/0014-5793(71)80067-4

PMID:11945802

Abstract

摘要

相似文献

A structural aspect of human fibrinogen suggested by its plasmin degradation.

FEBS Lett. 1971 Jun 2;15(1):13-16. doi: 10.1016/0014-5793(71)80067-4.

Platelet fibrinogen. Identity and initial observations on the mode of its degradation by plasmin.血小板纤维蛋白原。其纤溶酶降解模式的鉴定及初步观察。

Biochim Biophys Acta. 1975 Mar 28;386(1):209-20. doi: 10.1016/0005-2795(75)90261-5.

The role of the lysine binding sites of human plasmin in the hydrolysis of human fibrinogen.人纤溶酶赖氨酸结合位点在人纤维蛋白原水解中的作用。

Biochim Biophys Acta. 1983 Apr 14;744(1):99-104. doi: 10.1016/0167-4838(83)90345-x.

Factors influencing the structure of terminal plasmin degradation products of human fibrinogen and fibrin.

Biochim Biophys Acta. 1981 Feb 27;667(2):321-7. doi: 10.1016/0005-2795(81)90198-7.

Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.

Haemostasis. 1978;7(1):26-34. doi: 10.1159/000214229.

Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.钙调节纤维蛋白原D片段γ链N端的纤溶酶切割：单克隆抗体J88B在γ链纤溶酶敏感结构域的定位。

Biochim Biophys Acta. 1996 Nov 14;1298(1):69-77. doi: 10.1016/s0167-4838(96)00090-8.

In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.纤溶酶对血浆中人类血小板功能的体外作用。对纤维蛋白原溶解引起的聚集的抑制作用。

Circulation. 1992 Mar;85(3):935-41. doi: 10.1161/01.cir.85.3.935.

Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.尿激酶在人血浆中产生的纤溶酶原和纤溶酶的不同分子形式及其与蛋白酶抑制剂以及纤维蛋白原和纤维蛋白溶解的关系。

Biochem J. 1974 Nov;143(2):273-83. doi: 10.1042/bj1430273.

Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.

Proc Natl Acad Sci U S A. 1989 May;86(10):3847-51. doi: 10.1073/pnas.86.10.3847.

Degradation pathway of fibrinogen by plasmin.纤溶酶介导的纤维蛋白原降解途径。

Thromb Haemost. 1977 Dec 15;38(4):793-800.

引用本文的文献

Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom.从珊瑚蛇（Micrurus tener tener）毒液中纯化并鉴定具有抗纤溶酶活性的丝氨酸肽酶抑制剂tenerplasminin-1。

Comp Biochem Physiol C Toxicol Pharmacol. 2016 Jan;179:107-15. doi: 10.1016/j.cbpc.2015.09.009. Epub 2015 Sep 28.

Some aspects of the molecular pathology of thrombosis and haemorrhage.血栓形成与出血的分子病理学的某些方面。

Ir J Med Sci. 1984 Jan;153(1):2-10. doi: 10.1007/BF02940516.

Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.纤维蛋白和纤维蛋白原的降解产物：分子机制及临床意义

J Clin Pathol Suppl (R Coll Pathol). 1980;14:10-7.

Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure.交联纤维蛋白的血浆降解。新型大分子可溶性复合物的表征及其结构模型。

J Clin Invest. 1980 Nov;66(5):1033-43. doi: 10.1172/JCI109931.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验